A Randomized, Active Controlled, Parallel Group, Multi-Center, Two Stage, Open Label, Study Comparing Safety and Immunogenicity of Insugen R and Insugen N with Actrapid and Insulatard in Patients with Type 1 Diabetes Mellitus.

Trial Profile

A Randomized, Active Controlled, Parallel Group, Multi-Center, Two Stage, Open Label, Study Comparing Safety and Immunogenicity of Insugen R and Insugen N with Actrapid and Insulatard in Patients with Type 1 Diabetes Mellitus.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2016

At a glance

  • Drugs Insulin; Insulin suspension isophane
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Biocon
  • Most Recent Events

    • 11 Jun 2010 Status changed from not yet recruiting to discontinued as reported by Clinical Trials Registry - India.
    • 01 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top